Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | NOS3 | P29474 | 1/20 | 0.34 |
| ▸ | NOS1 | P29475 | 1/20 | 0.34 |
| ▸ | NOS2 | P35228 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | RXRA | P19793 | 1/20 | 0.30 |
| ▸ | RXRB | P28702 | 1/20 | 0.30 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28453454 | 0.97 | PTGS2 (0.36) | PTGS2TP53NOS3NOS1NOS2 | |
| SCHEMBL5050077 | 0.92 | PTGS2 (0.33) | PTGS2TP53NOS3NOS1NOS2 | |
| SCHEMBL28090050 | 0.88 | TAAR1 (0.33) | PTGS2NOS3NOS1NOS2 | |
| SCHEMBL15068068 | 0.87 | PTGS2 (0.33) | PTGS2TP53NOS3NOS1NOS2 | |
| SCHEMBL2467446 | 0.86 | — | — | |
| SCHEMBL509622 | 0.85 | PTGS2 (0.32) | PTGS2NOS3NOS1NOS2 | |
| SCHEMBL15063544 | 0.83 | PTGS2 (0.31) | PTGS2 | |
| SCHEMBL15063904 | 0.83 | PTGS2 (0.31) | PTGS2 | |
| SCHEMBL15064193 | 0.83 | PTGS2 (0.31) | PTGS2 | |
| SCHEMBL27382724 | 0.81 | LOXL2 (0.32) | NOS3NOS1NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1364 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118344695-A | Hydroxyl-enriched cycloolefin copolymer long afterglow material and application thereof | 重庆理工大学 | 2024-07-16 | — | — | CN | claimed |
| US-20240216900-A1 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | THE U.S.A., AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-07-04 | — | — | US | claimed |
| CN-117551134-A | Complex and preparation method and application thereof | 南京佳诺霖光电科技有限公司 | 2024-02-13 | — | — | CN | claimed |
| WO-2024022413-A1 | DIVALENT METAL COMPLEX, PREPARATION METHOD THEREFOR AND USE THEREOF, AND ORGANIC OPTOELECTRONIC DEVICE | 中国石油化工股份有限公司 | 2024-02-01 | — | — | WO | claimed |
| CN-117466944-A | Divalent metal complex, preparation method and application thereof, and organic photoelectric device | 中国石油化工股份有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-113260603-B | Preparation of 5-aryl pentanols | 巴斯夫欧洲公司 | 2023-12-01 | — | — | CN | claimed |
| WO-2023196594-A2 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-10-12 | — | — | WO | claimed |
| CN-116574136-A | Bivalent platinum complex and preparation method and application thereof | 南京佳诺霖光电科技有限公司 | 2023-08-11 | — | — | CN | claimed |
| CN-116554372-A | Preparation method of low-entanglement ultra-high molecular weight polyethylene | 中国科学院长春应用化学研究所 | 2023-08-08 | — | — | CN | claimed |
| EP-3908566-B1 | PREPARATION OF 5-ARYL PENTANOLS | BASF SE (DE) | 2023-07-26 | — | — | EP | claimed |
| US-20050245555-A1 | Tri-substituted ureas as cytokine inhibitors | THE PROCTER & GAMBLE COMPANY (US) | 2005-11-03 | — | — | US | claimed |
| CN-1202049-C | Iron-based catalyst composition for ethylene oligomerization and application thereof | CHINA NAT PETROLEUM CORP (CN) | 2005-05-18 | — | — | CN | claimed |
| CN-1463799-A | Binuclear iron-based catalyst composition for preparing alpha-olefin by ethylene oligomerization and method for preparing linear alpha-olefin | PETROCHINA CO LTD (CN) | 2003-12-31 | — | — | CN | claimed |
| CN-1463800-A | Binuclear cobalt catalyst composition for synthesizing linear alpha-olefin by ethylene oligomerization and method for preparing linear alpha-olefin | PETROCHINA CO LTD (CN) | 2003-12-31 | — | — | CN | claimed |
| US-20030100689-A1 | Polymerisation catalyst | BP CHEMICALS LIMITED (GB) | 2003-05-29 | — | — | US | claimed |
| CN-1403424-A | Cobalt catalyst composition for ethylene oligomerization and preparation method of alpha-olefin | CHINA NAT PETROLEUM CORP (CN) | 2003-03-19 | — | — | CN | claimed |
| CN-1374281-A | Iron-based catalyst composition for ethylene oligomerization and preparation method of alpha-olefin | CHINA PETROLEUM CORP (CN) | 2002-10-16 | — | — | CN | claimed |
| US-20020045747-A1 | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds | WU JING (US) | 2002-04-18 | — | — | US | claimed |
| US-RE37094-E1 | Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them | SANOFI (FR) | 2001-03-13 | — | — | US | claimed |
| WO-2000003803-A1 | CATALYST COMPOSITION | BP CHEMICALS LIMITED (GB) | 2000-01-27 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050245555-A1 | Tri-substituted ureas as cytokine inhibitors | IL1B, IL1A, IL6 | PTGS2 541/4885TP53 1178/4885NOS3 258/4885 |
| US-20240216900-A1 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | FABP7, FFAR1, FABP1 | PTGS2 3794/4885TP53 2915/4885NOS3 3447/4885 |
| US-20030100689-A1 | Polymerisation catalyst | NR1H2, NR1H3, MT-CO1 | PTGS2 3172/4885TP53 4439/4885NOS3 1611/4885 |
| US-20020045747-A1 | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds | BACE1, APP, BACE2 | PTGS2 841/4885TP53 2033/4885NOS3 1769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.